The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...
Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. Learn why ...
2h
MarketBeat on MSNPharma Frenzy: Volatility Ignites Biotech SectorThe biotechnology sector has experienced a jolt of volatility over the past few days, spearheaded by the dramatic price ...
WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...
4hOpinion
Zacks Investment Research on MSN5 Large Drug Stocks to Watch as Industry RecoversThe drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...
5d
Zacks.com on MSNARS Pharmaceuticals, Inc. (SPRY) Q4 Earnings and Revenues Beat EstimatesARS Pharmaceuticals, Inc. (SPRY) delivered earnings and revenue surprises of 1,400% and 273.26%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...
Sun Pharmaceutical Industries Limited has announced the completion of its 100% acquisition of Antibe Therapeutics Inc., a ...
5d
The Print on MSNHow reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the USSpooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...
ARS Pharmaceuticals, Inc. , which belongs to the Zacks Medical - Drugs industry, posted revenues of $86.58 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by ...
Analysts have set 12-month price targets for Eton Pharmaceuticals, revealing an average target of $24.4, a high estimate of $33.00, and a low estimate of $17.00. Marking an increase of 22.0%, the ...
MM+M Agency 100 issue is nominated for Best Single Issue of a Tabloid/Newspaper/Magazine for a brand with revenue between $3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results